← Back to Clinical Trials
Recruiting NCT07370428

NCT07370428 US-Guided Quadro-Iliac Plane Block for Postoperative Analgesia After Lumbar Instrumentation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07370428
Status Recruiting
Phase
Sponsor Bursa City Hospital
Condition Postoperative Pain
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-01-20
Primary Completion 2026-03-31

Trial Parameters

Condition Postoperative Pain
Sponsor Bursa City Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2026-01-20
Completion 2026-03-31
Interventions
Quadro-Iliac Plane Block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Lumbar instrumentation surgery is associated with significant postoperative pain. This study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane Block in patients undergoing lumbar instrumentation surgery, aiming to assess the efficacy of this newly developed technique for postoperative pain management.

Eligibility Criteria

Inclusion Criteria: * Classified as American Society of Anesthesiologists (ASA) physical status I-III * Scheduled for elective lumbar instrumentation surgery * Surgery performed under general anesthesia * Provision of written informed consent Exclusion Criteria: * Use of anticoagulant or antiplatelet medications * Presence of bleeding diathesis or coagulation disorders * Known allergy or hypersensitivity to local anesthetics or opioid medications * Infection at the planned block site * Alcohol or drug dependence * Cognitive impairment preventing reliable pain assessment using the NRS * Pregnancy or lactation * History of previous lumbar spine surgery * Diabetes mellitus * Renal or hepatic impairment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology